Endothelial dysfunction in PCOS: Role of obesity and adipose hormones

American Journal of Medicine

Volumn 119, Issue 4, 2006, Pages

  Carmina, E ^a   Orio, F ^b   Palomba, S ^c   Longo, R A ^a   Cascella, T ^b   Colao, A ^b   Lombardi, G ^b   Rini, G B ^a   Lobo, Rogerio A ^d,e  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e PH 16 ^*  (United States)

Author keywords

Adiponectin; Endothelium; Insulin; Leptin; PCOS

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; INSULIN; LEPTIN; RESISTIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD ANALYSIS; BODY MASS; BRACHIAL ARTERY; CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INSULIN RESISTANCE; INTIMA; OBESITY; OVARY POLYCYSTIC DISEASE; PARAMETER; PRIORITY JOURNAL; RISK FACTOR; TUNICA MEDIA; VASODILATATION;

ADIPOCYTES; ADIPONECTIN; ADULT; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; BODY FAT DISTRIBUTION; BODY MASS INDEX; BRACHIAL ARTERY; CAROTID ARTERIES; CASE-CONTROL STUDIES; CYTOKINES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; OBESITY; PEPTIDE HORMONES; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; RESISTIN; TUNICA INTIMA; TUNICA MEDIA; VASODILATION;

EID: 33645237483     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.10.059     Document Type: Article

References (47)

1. R.A. Lobo, E. Carmina The importance of diagnosing the polycystic ovary syndrome Ann Intern Med 132 2000 989 993
2. D. Cibula, R. Cifkova, M. Fanta, R. Poledne, J. Zivny, J. Skibova Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of polycystic ovary syndrome Hum Reprod. 15 2000 785 789
3. E. Carmina, R.A. Lobo Polycystic ovaries in hirsute women with normal menses Am J Med 111 2001 602 606
4. R.A. Wild, P.C. Painter, P.B. Coulson, K.B. Carruth, G.B. Ranney Lipoprotein lipid concentration and cardiovascular risk in women with polycystic ovary syndrome J Clin Endocrinol Metab 61 1985 946 951
5. M.J. Graf, C.J. Richards, V. Brown, L. Meissner, A. Dunaif The independent effects of hyperandrogenemia, hyperinsulinemia and obesity on lipid and lipoprotein profiles in women Clin Endocrin Metabol 33 1990 119 131
6. C.J.G. Kelly, A. Speirs, G.W. Gould, J.R. Petrie, H. Lyall, J.M.C. Connell Altered vascular function in young women with polycystic ovary syndrome J Clin Endocrinol Metab 87 2002 742 746
7. N. Boulman, Y. Levy, R. Leiba Increased C-reactive protein levels in the polycystic ovary syndrome a marker of cardiovascular disease J Clin Endocrinol Metab 89 2004 2160 2165
8. L. Morin-Papunen, K. Rautio, A. Ruokonen, P. Hedberg, M. Puukka, J.S. Tapanainen Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome J Clin Endocrinol Metab 88 2003 4649 4654
9. F. Orio Jr, S. Palomba, S. Di Biase Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome J Clin Endocrinol Metab 88 2003 673 679
10. E. Diamanti-Kandarakis, G. Spina, C. Kouli, I. Migdalis Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy J Clin Endocrinol Metab 86 2001 4666 4673
11. D.A. Ehrmann, D.J. Schneider, B.E. Sobel Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome J Clin Endocrinol Metab 82 1997 2108 2116
12. G. Paradisi, H.O. Steinberg, A. Hempfling Polycystic ovary syndrome is associated with endothelial dysfunction Circulation 103 2001 1410 1415
13. G. Paradisi, H.O. Steinberg, K.S. Marguette, H. Ginger, A.D. Baron Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome J Clin Endocrinol Metab 88 2003 576 580
14. M.A. Birdsall, C.M. Farquhar, H.D. White Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization Ann Intern Med 126 1997 32 35
15. R.C. Christian, D.A. Dumesic, T. Behrenbeck, A.L. Oberg, P.F. Sheedy II, L.A. Fitzpatrick Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome J Clin Endocrinol Metab 88 2003 2562 2568
16. E.O. Talbott, J.V. Zborowski, J.R. Rager, M.Y. Boudreaux, D.A. Edmundowicz, D.S. Guzick Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic syndrome J Clin Endocrinol Metab 89 2004 5454 5461
17. D.S. Guzick, E.O. Talbott, K. Sutton-Tyrrell, H.C. Herzog, L.H. Kuller, S.K. Wolfson Jr Carotid atherosclerosis in women with polycystic ovary syndrome initial results from a case-control study Am J Obstet Gynecol 174 1996 1224 1229
18. K. Lakhani, P. Hardiman, A.M. Seifalian Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries Atherosclerosis 175 2004 353 359
19. F. Orio Jr, S. Palomba, T. Cascella Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome J Clin Endocrinol Metab 89 2004 4588 4593
20. E.O. Talbott, J.V. Zborowski, M.Y. Boudreaux, K.P. McHugh-Pemu, K. Sutton-Tyrrel, D.S. Guzick The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome J Clin Endocrinol Metab 89 2004 6061 6067
21. K. Matsumura, T. Tsuchihashi, K. Fujii, M. Iida Neural regulation of blood pressure by leptin and the related peptides Regul Pept 114 2003 79 86
22. G. Fantuzzi, R. Faggioni Leptin in the regulation of immunity, inflammation and hematopoiesis J Leukoc Biol 68 2003 437 446
23. F.M.H. Van Dielen, C. van't Veer, A.M. Schols, P.B. Soeters, W.A. Buurman, J.W.M. Greve Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals Int J Obes Relat Metabc Disord. 25 2001 1759 1766
24. C.J. Hukshorn, J.H.N. Lindeman, K.H. Toet Leptin and the proinflammatory state associated with human obesity J Clin Endocrinol Metab 89 2004 1773 1778
25. B.J. Goldstein, R. Scalia Adiponectin a novel adipokine linking adipocytes and vascular function J Clin Endocrinol Metab 89 2004 2563 2568
26. N. Ouchi, M. Ohishi, S. Kihara Association of hypoadiponectinemia with impaired vasoreactivity Hypertension 42 2003 231 234
27. K.C. Tan, A. Xu, W.S. Chow Hypoadiponectinemia is associated with impaired vasoreactivity J Clin Endocrinol Metab 89 2004 765 769
28. H. Motoshima, X. Wu, K. Mahadev, B.J. Goldstein Adiponectin suppresses proliferation and superoxide generation and enhances NOS activity in endothelial cells treated with oxidized LDL Biochem Biophys Res Commun 315 2003 264 271
29. J.M. Fernandez-Real, A. Castro, G. Vazquez Adiponectin is associated with vascular function independent ofinsulin sensitivity Diabetes Care 27 2004 739 745
30. M. Matsuda, I. Shimomura, M. Sata Role of adiponectin in preventing vascular stenosis the missing link of adipovascular axis J Biol Chem 277 2002 37487 37491
31. Y. Okamoto, S. Kihara, N. Ouchi Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice Circulation 106 2002 2767 2770
32. M. Degawa-Yamauchi, J.E. Bovenkerk, B.E. Juliar Serum resistin (FIZZ3) protein is increased in obese humans J Clin Endocrinol Metab 88 2003 5452 5455
33. C.M. Steppan, S.T. Bailey, S. Bhat The hormone resistin links obesity to diabetes Nature 409 2001 307 312
34. D. Kawanami, K. Maemura, N. Takeda Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells a new insight into adipocytokine-endothelial interactions Biochem Biophys Res Commun 314 2004 415 419
35. A. Katz, S.N. Sridhar, K. Mather Quantitative insulin-sensitivity check index a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 2000 2402 2410
36. M.C. Corretti, T.J. Anderson, E.J. Benjamin International Brachial Artery Reactivity Task Force 2002. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265
37. J.R. Crouse 3rd, T.E. Craven, A.P. Hagaman, M.G. Bond Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery Circulation 92 1995 1141 1147
38. J.T. Salonen, R. Salonen Ultrasonographically assessed carotid morphology and the risk of coronary heart disease Arterioscler Thromb Vasc Biol 11 1991 1245 1249
39. G. Gamble, B. Beaumont, H. Smith B-mode ultrasound images of the carotid artery wall correlation of ultrasound with histological measurements Atherosclerosis 102 1993 163 173
40. L. Mykkanen, D.J. Zaccaro, D.H. O'Leary, G. Howard, D.C. Robbins, S.M. Haffner Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The insulin resistance atherosclerosis study (IRAS) Stroke 28 1997 1710 1716
41. Y. Sun, C.H. Lin, C.J. Lu, P.K. Yip, R.C. Chen Carotid atherosclerosis, intima media thickness and risk factors-an analysis of 1781 asymptomatic subjects in Taiwan Atherosclerosis 164 2002 89 94
42. N. Pannacciulli, G. De Pergola, M. Ciccone, P. Rizzoni, F. Giorgino, R. Giorgino Effect of family story of type 2 diabetes on the intima-media thickness of the common carotid artery in normal-weight, overweight, and obese glucose tolerant young adults Diabetes Care 26 2003 1230 1234
43. K.J. Mather, S. Verma, B. Corenblum, T.J. Anderson Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome J Clin Endocrinol Metab 85 2000 1851 1856
44. F. Orio Jr, S. Palomba, T. Cascella Adinopectin levels in women with polycystic ova syndrome J Clin Endocrinol Metab 88 2003 2619 2623
45. B.L. Wajchenberg Subcutaneous and visceral adipose tissue their relation to the metabolic syndrome Endocr Rev 21 2002 697 738
46. T. Masaki, S. Chiba, T. Yasuda Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice Diabetes 52 2003 2266 2273
47. R.S. Legro Polycystic ovary sindrome and cardiovascular disease a premature association? Endocr Rev 24 2003 302 312